Try our beta test site
19 studies found for:    Open Studies | "Nail Diseases"
Show Display Options
Rank Status Study
1 Not yet recruiting Clinical Efficacy of Nail Brace for Treatment of Ingrown Toenails
Condition: Ingrown Nail
Interventions: Device: Podofix nail brace;   Device: Combiped nail brace;   Device: Podofix and then Combiped nail brace
2 Recruiting A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis
Conditions: Breast Cancer;   Docetaxel Chemotherapy
Intervention: Drug: EVONAIL® solution
3 Recruiting Real-World Evaluation of the Effect of Jublia on Nail Polish
Condition: Distal Lateral Subungual Onychomycosis (DLSO)
Interventions: Drug: Jublia;   Other: Nail polish
4 Recruiting Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis
Condition: Toenail Onychomycosis
Intervention: Procedure: Aminolevulinic Acid (ALA)
5 Not yet recruiting Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
Condition: Onychomycosis
Interventions: Device: Nailner 2 in 1;   Drug: Ciclopirox 8%
6 Recruiting Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
Condition: Onychomycosis
Interventions: Drug: NVXT topical;   Drug: Placebo (Vehicle) Topical
7 Recruiting Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: Ciclopirox 80 mg/g
8 Recruiting A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: MOB015B Vehicle
9 Recruiting Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Condition: Onychomycosis
Intervention: Drug: Efinaconazole
10 Recruiting Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis
Condition: Non-dermatophyte Onychomycosis
Interventions: Device: 1,064nm Long-pulsed Nd:YAG;   Drug: Amorolfine
11 Recruiting Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
Condition: Onychomycosis
Intervention: Drug: HTS-519 Insert
12 Recruiting Evaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of Onychomycosis
Condition: Onychomycosis
Interventions: Device: MOE Plasma Delivery System A;   Device: MOE Plasma Delivery System B
13 Recruiting The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis
Condition: Onychomycosis
Interventions: Drug: CELEXT07;   Drug: Penlac;   Other: vehicle solution
14 Recruiting Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis
Condition: Onychomycosis
Interventions: Drug: P-3058 10%;   Drug: vehicle of P-3058 10%;   Drug: amorolfine 5%
15 Recruiting Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population
Condition: Onychomycosis
Intervention: Drug: P-3058
16 Recruiting Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis
Condition: Onychomycosis
Intervention: Device: CURE-EX device
17 Recruiting Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Conditions: Epidermolysis Bullosa Simplex;   Pachyonychia Congenita
Interventions: Drug: Jojoba oil with broccoli sprout extract;   Drug: Jojoba oil (placebo)
18 Recruiting International Pachyonychia Congenita Research Registry
Condition: Pachyonychia Congenita
Intervention:
19 Not yet recruiting Laser Treatment for Onychomycosis in Diabetes
Conditions: Diabetes Mellitus, Type 2;   Onychomycosis
Interventions: Device: Laser Treatment YAG laser;   Drug: Standard Treatment (control group) terbinafine hydrochloride tablets

Study has passed its completion date and status has not been verified in more than two years.